Impact of Soybean Phytoestrogen-Rich Extract on Markers of Inflammation Markers in 4-Vinyl Cyclohexane Diepoxide-Induced Menopause in Albino Rats
DOI:
https://doi.org/10.31964/mltj.v9i2.549Keywords:
4-vinyl cyclohexane diepoxide, inflammation, menopause, phytoestrogenAbstract
The vasomotor symptoms of menopause, including hot flashes, sweating, physical and psychological discomfort, and emotional changes, are accurate and experienced by many of the menopausal and postmenopausal female population. In addition, it causes osteoporosis and slowed metabolism, raising the chance of developing many different ailments. Given that hormone replacement therapy (HRT) has been linked to an increased cancer risk, this investigation was undertaken to identify viable alternatives. The study aimed to investigate the impact of Soybean phytoestrogen-rich extract on some markers of inflammation of 4-vinyl cyclohexene diepoxide-induced menopause in albino rats. Sixty-five (65) female albino Wistar rats were employed in the investigation. Each one was induced with 80mg/kg of 4-vinyl cyclohexene diepoxide before being treated with either normal estradiol therapy (14ug/kg) or varying concentrations of the soybean phytoestrogen-rich extract (200 mg/kg, 400 mg/kg, and 600 mg/kg). Inflammatory markers (C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-α)) were measured by ELISA methods. Statistical software SPSS (IBM) version 23.0 was used to analyze the data. Compared to the positive control group, the soybean phytoestrogen-rich extract therapy group saw a dose-dependent reduction in CRP and IL-6 levels (p<0.05) but not in TNF-α (P>0.05). Data from this research demonstrate the anti-inflammatory effects of soybean phytoestrogen-rich extract therapy in menopause-induced female Wistar rats. Soybean phytoestrogen-rich extract therapy in a high dose appears to show no significant difference from hormone replacement therapy as an alternate estrogen source in managing inflammation as a chronic disease.References
Alvehus, M., Simonyte, K., Andersson, T., Söderström, I., Burén, J., Rask, E., Mattsson, C. and Olsson, T. (2012). Adipose tissue IL-8 is increased in normal weight women after menopause and reduced after gastric bypass surgery in obese women: IL-8 levels in normal weight and obese women. Clinical Endocrinology. 77(5), 684–690.
Azadbakht, L., Kimiagar, M., Mehrabi, Y., Esmaillzadeh, A., Hu, F.B. and Willett, W.C. (2007). Soy consumption, markers of inflammation, and endothelial function: A cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care. 30(4), 967–973.
Barber, C.A., Margolis, K., Luepker, R.V. and Arnett, D.K. (2004). The impact of the Women’s Health Initiative on discontinuation of postmenopausal hormone therapy: The Minnesota Heart Survey (2000–2002). Journal of Womens Health. 13(9): 975–985.
Barnes, S. (2010). The Biochemistry, Chemistry and Physiology of the Isoflavones in Soybeans and their Food Products. Lymphatic Research and Biology. 8(1), 89–98.
Blay, M., Espinel, A., Delgado, M., Baiges, I., Blade, C., Arola, L. and Salvado, J. (2010). Isoflavone effect on gene expression profile and biomarkers of inflammation. Journal of Pharmaceutical and Biomedical Analysis. 51(2), 382–390.
Butler, L. and Santoro, N. (2011). The reproductive endocrimiology of its menopausal transition. Steroids. 76(7): 627-635.
Chalopin, M., Tesse, A., Martinez, M.C., Rognan, D., Arnal, J.F. and Andriantsitohaina, R. (2010). Estrogen receptor alpha as a key target of red wine polyphenols action on the endothelium. PLoS One. 5(1): e8554.
Cvejic, J., Malencic, D., Tepavcevic, V., Posia, M. and Miladinovic, J. (2009). Determination of Phytoestrogen Composition in Soybean Cultivars in Serbia. Natural Products Communications. 4(8): 1069-1074.
De Franciscis, P., Colacurci, N., Riemma, G., Conte, A., Pittana, E., Guida, M. and Schiattarella, A. (2019). A nutraceutical approach to menopausal complaints. Medicina, 55(9), 544.
Dutta, D.C. (2004). Text book of Gynaecology. (5th edition). New central book agency (P) Ltd. India.
Eckersall, P.D., Conner, J.G and Harvie, J. (1991). An immunoturidimetric assay for canine C-reactive protein. Verterinary Research Communications, 15(1):17-24
Ganai, A.A., Khan, A.A., Malik, Z.A. and Farooqi, H. (2015). Genistein modulates the expression of nf-kappab and mapk (p-38 and erk1/2), thereby attenuating d-galactosamine induced fulminant hepatic failure in wistar rats. Toxicology and Applied Pharmacology. 283(2), 139–146.
Giolo, J.S., Costa, J.G., Da Cunha-Junior, J.P., Pajuaba, A.C.A.M., Taketomi, E.A., De Souza, A.V., Caixeta, D.C., Peixoto, L.G., De Oliveira, E.P. and Everman, S. (2018). The Effects of Isoflavone Supplementation Plus Combined Exercise on Lipid Levels, and Inflammatory and Oxidative Stress Markers in Postmenopausal Women. Nutrients. 10(4), 424.
Guo, P.P., Li, P., Zhang, X.H., Liu, N., Wang, J., Chen, D.D., Sun, W.J. and Zhang, W. (2019). Complementary and alternative medicine for natural and treatment-induced vasomotor symptoms: An overview of systematic reviews and meta-analyses. Complementary Therapies in Clinical Practice. 36, 181–194.
Hill, D.A., Crider, M. and Hill, S.R. (2016). Hormone therapy and other treatments for symptoms of menopause. American Family Physician. 94(11), 884–889.
Hill, K. (1996). The Demographic of Menopause. Maturity Journal. 23(2) 113-127
Jantaratnotai, N., Utaisincharoen, P., Sanvarinda, P., Thampithak, A. and Sanvarinda, Y. (2013). Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia. International journal of Immunopharmacology. 17(2), 483–488.
Ji, G., Zhang, Y., Yang, Q., Cheng, S., Hao, J., Zhao, X. and Jiang Z. (2012). Genistein suppresses lps-induced inflammatory response through inhibiting nf-κb following amp kinase activation in raw 264.7 macrophages. PLoS ONE. 7(12), 361.
Kaneko, M., Stellwaen, D., Malenka, R.C. and Stryker, M.P. (2008). Tumour necrosis factor-a mmediates one component of competitive, experience-dependent plasticity in developing visual cortex. Neuron, 58(5): 673-680.
Kao, T.H., Wu, W.M., Hung, C.F., Wu, W.B. and Chen, B.H. (2007). Anti-inflammatory effects of isoflavone powder produced from soybean cake. Journal of Agriculture and Food Chemistry. 55(26), 11068–11079.
Krause, M., Wheeler, T.L., Snyder, T.E., Richter, H.E. (2009). Local Effects of Vaginally Administered Estrogen Therapy: A Review. Journal of Pelvic Medicine Surgery. 15(3), 105-114.
Krebs, E.E., Ensrud, K.E., MacDonald, R. and Wilt, T.J. (2004). Phytoestrogens for treatment of menopausal symptoms: A systematic review. Obstetric and Gynecology. 104(4), 824–836.
Lebon, J., Riesco, E., Tessier, D. and Dionne, I.J. (2014). Additive effects of isoflavones and exercise training on inflammatory cytokines and body composition in overweight and obese postmenopausal women: A randomized controlled trial. Menopause. 21(8), 869–875.
Lesinski, G.B., Reville, P.K., Mace, T.A., Young, G.S., Ahn-Jarvis, J., Thomas-Ahner, J., Vodovotz, Y., Ameen, Z., Grainger, E. and Riedl, K. (2015). Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells. Cancer Prevention Research. 8(11), 1036–1044.
Mendelsohn, M.E. and Karas, R.H. (2005). Molecular and cellular basis of cardiovascular gender differences. Science. 308(5728), 1583-1587.
Nelson, H. D. (2008). Menopause. Lancet. 371(9614), 760-770.
Paradkar, P.N., Blum, P.S., Berhow, M.A., Baumann, H. and Kuo, S.M. (2004). Dietary isoflavones suppress endotoxin-induced inflammatory reaction in liver and intestine. Cancer Letter. 215(1), 21–28.
Park, J., Kim, D. H., Ahn, H.N., Song, Y.S., Lee, Y.J. and Ryu, J.H. (2012). Activation of estrogen receptor by bavachin from Psoralea corylifolia. Biomolecular Therapy (Seoul). 20(2), 183– 188.
Pilsakova, L., Riecansky, I. and Jagla, F. (2010). The physiological actions of isoflavone phytoestrogens. Physiological Research. 59(5), 651-664.
Sadeghalvad, M., Mohammadi-Motlagh, H.-R., Karaji, A.G. and Mostafaie, A. (2019). In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean. Journal of Biochemistry, Molecular and Toxicology. 33(12), e22406.
Santer, F.R., Malinowska, K., Culig, Z., Cavaretta, I.T. (2010). Interleukin-6-trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells. Endocrine Related Cancer, 17(1), 241-253.
Somekawa, Y., Chiguchi, M., Ishibashi, T. and Takeshi, A. (2001). Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstetrics and Gynecology 97(1), 109–115.
Suri, V. and Suri, V. (2014). Menopause and oral health. Journal of Midlife Health. 5(3), 115-120.
Tidke, S., Mahajankat, A., Devasurmutt, Y., Devappa, R., Vasist, K.S., Kosturkova, G. and Gokare, R. (2018). Assessment of Anticancer, Anti-inflammatory and Antioxidant Properties of Isoflavones Present in Soybean. Research Journal of Phytochemistry. 12(1), 35–42.
Tousoulis, D., Kampoli, A.M., Tentolouris, C., Papageorgiou, N. and Stefanadis, C. (2012). The role of nitric oxide on endothelial function. Current Vascular Pharmacology. 10(1), 4–18.
Valdes, A., Bajaj, T. (2023). Estrogen Therapy. In: StatPearls.Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK541051/. Accessed 10th August, 2023
Verdrengh, M., Jonsson, I.M., Holmdahl, R. and Tarkowski, A. (2003). Genistein as an anti-inflammatory agent. Inflamm. Res. Off. Journal of European Histamine Research Society, 52(8), 341–346.
Villablanca, A., Tetali, S., Altman, R., Ng, K.F. and Rutledge, J.C. (2013). Testosterone-derived estradiol production by male endothelium is robust and dependent on p450 aromatase via estrogen receptor alpha. Springer Plus, 2(1), 214.
WHO. (2007). United Nations, Department of Econonomic and Social Affair, Population division: World Population Ageing Fact Sheet Highlight P. 212
World Bank. (1993). World Development Report: Investing in Health, New York, New York University Press, P.204.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Edusola Juliana Olaniyan, Mathias Abiodun Emokpae, Fidelis Ohiremen Oyakhire, Ahmed Liasu Adeagbo, Iria Kelly Esezobor, Stephen Olawale Olaniyan

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.
MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.